PROTOCOL IN PATIENTS (PTS) TREATED FOR PAIN IN BONE METASTASIS (MTS): IS THERE A ROLE FOR ORAL TRANSMUCOSAL FENTANYL CITRATE (OTFC)?

被引:0
|
作者
Daidone, A. [1 ]
Moscadini, L. [1 ]
Grillo, A. [1 ]
Mangiapane, M. [1 ]
Valentina, V. Gruppuso [1 ]
Guerrieri, P. [1 ]
Montemaggi, P. [1 ]
机构
[1] Maurizio Ascoli, Dept Radiat Oncol, Palermo, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1120
引用
收藏
页码:S378 / S378
页数:1
相关论文
共 50 条
  • [1] ORAL TRANSMUCOSAL FENTANYL CITRATE (OTFC) FOR THE TREATMENT OF POSTOPERATIVE PAIN
    ASHBURN, MA
    LIND, GH
    GILLIE, MH
    DEBOER, AJF
    PACE, NL
    STANLEY, TH
    ANESTHESIA AND ANALGESIA, 1993, 76 (02): : 377 - 381
  • [2] Oral transmucosal fentanyl citrate -: OTFC (ACTIQ™) #103
    Gordon, Debra
    Schroeder, Mark
    JOURNAL OF PALLIATIVE MEDICINE, 2008, 11 (04) : 633 - 634
  • [3] Use of oral transmucosal fentanyl citrate (OTFC) in TRUS prostate biopsy patients
    Sharma, H.
    Maheshkumar, P.
    BJU INTERNATIONAL, 2009, 103 : 12 - 12
  • [4] Oral transmucosal fentanyl citrate (OTFC) compared with IV morphine for acute pain in patients following abdominal surgery
    Sevarino, FB
    Ginsberg, B
    Lichtor, JL
    Joshi, GP
    Nordbrock, E
    Busch, MA
    ANESTHESIA AND ANALGESIA, 1997, 84 : S330 - S330
  • [5] AN OPEN LABEL STUDY OF ORAL TRANSMUCOSAL FENTANYL CITRATE (OTFC) FOR THE TREATMENT OF BREAKTHROUGH CANCER PAIN
    FINE, PG
    MARCUS, M
    DEBOER, AJ
    VANDEROORD, B
    PAIN, 1991, 45 (02) : 149 - 153
  • [6] Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study
    Portenoy, RK
    Payne, R
    Coluzzi, P
    Raschko, JW
    Lyss, A
    Busch, MA
    Frigerio, V
    Ingham, J
    Loseth, DB
    Nordbrock, E
    Rhiner, M
    PAIN, 1999, 79 (2-3) : 303 - 312
  • [7] Evidence-based oral transmucosal fentanyl citrate (OTFC®) dosing guidelines
    Aronoff, GM
    Brennan, MJ
    Pritchard, DD
    Ginsberg, B
    PAIN MEDICINE, 2005, 6 (04) : 305 - 314
  • [8] A new method for titration of oral transmucosal fentanyl citrate (OTFC) starting dose in cancer patients
    Scandurra, G.
    Ferraro, G.
    Franchina, T.
    Chiofalo, G.
    Zanghi, M.
    Festa, V
    Pastura, G.
    Adamo, V
    ANNALS OF ONCOLOGY, 2006, 17 : XI70 - XI70
  • [9] Influence of CYP3A activity on the effects of oral transmucosal fentanyl citrate (OTFC).
    Kharasch, ED
    Hoffer, CJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P26 - P26
  • [10] Oral transmucosal fentanyl citrate for the treatment of breakthrough pain
    Zarth, R.
    Ehmer, M.
    Sittig, H. -B.
    SCHMERZ, 2007, 21 (06): : 545 - 552